Who owns Code Biotherapeutics?

Code Biotherapeutics is currently owned by 4Bio Partners, through 4BIO Ventures III, since 2022.

When did 4Bio Partners acquire Code Biotherapeutics?

4Bio Partners acquired Code Biotherapeutics in 2022 (active for 4 years).

Home/Companies/Biotech/Code Biotherapeutics

Code Biotherapeutics

Biotech·

US·Active·4yr hold

Code Biotherapeutics is a biotech company, headquartered in US.

Entry

2022

Hold

4yr

Status

Active

Est. EV

–

Investor

4Bio Partners

Key facts

HQUS

SectorBiotech

StatusActive

US biotechnology company pioneering non-viral targeted delivery of genetic medicines; 4BIO Capital joined its 2022 Series A financing.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from 4BIO Ventures III

Other portfolio companies in the same fund.

Cytospire Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated May 2026 · Sourced from public filings